|
|
| Volume 17 • Issue 6 |
March 22, 2017 |
 |
|
|
 |
| |
 |
|
|
IMPORTANT INFORMATION
PROLENSATM LABEL CHANGE
Bausch + Lomb Canada would like to inform you that there has been a label change for the product PROLENSATM.
Read more
|
|
|
|
| |
 |
|
|
BACK TO STOCK NOTIFICATION - ALDARAP® 5.0% PUMP 7.5G
Read more
|
|
|
|
| |
 |
|
|
IMPORTANT INFORMATION
TEMPORARY SHORTAGE OF LOVENOX® HP 120MG ENOXAPARIN SODIUM
(HIGH POTENCY) IN PREFILLED SYRINGES
Sanofi-aventis Canada Inc. would like to inform you that due to a supply delay, LOVENOX® HP 120mg in prefilled syringes will be on temporary backorder by the second week of March.
Read more
|
|
|
|
| |
 |
|
|
IMPORTANT INFORMATION
DISCONTINUATION OF LOTEMAX® SUSPENSION 0.5% W/V (5 ML)
Bausch + Lomb Canada would like to inform you that by the end of March 2017,
LOTEMAX® Suspension 0.5% w/v (5 mL only) will be discontinued.
Read more
|
|
 |
| |
 |
|
|
IMPORTANT INFORMATION
NOW AVAILABLE IN CANADA
Help treat the itch associated with Allergic Conjunctivitis.
Read more
|
|
 |
| |
 |
|
|
OUR IMMUNE HEALTH NEEDS DAILY SUPPORT
Our immune system needs daily support but busy schedules can get in the way.
COLD‑FX® can help!
Read more
|
|
 |
| |
 |
|
|
HOW KINERET® (ANAKINRA) IS DISTRIBUTED TO YOUR PATIENTS
IS CHANGING
Sobi Canada Inc. is changing its distribution model for obtaining KINERET. We are making this change in order to provide your patients with enhanced patient support services, including assistance with navigating reimbursement/insurance coverage, as well as direct-to-patient KINERET shipment. Read more
|
|
 |
|
|
